S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
OTCMKTS:BNTGF

Brenntag (BNTGF) Stock Forecast, Price & News

$79.00
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$79.00
$79.00
50-Day Range
$73.57
$81.75
52-Week Range
$54.03
$82.45
Volume
N/A
Average Volume
294 shs
Market Capitalization
N/A
P/E Ratio
34.04
Dividend Yield
1.10%
Price Target
N/A

Brenntag MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.01mentions of Brenntag in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.02 out of 5 stars


BNTGF stock logo

About Brenntag (OTCMKTS:BNTGF) Stock

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany and internationally. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries. The company was founded in 1874 and is based in Essen, Germany.

BNTGF Price History

BNTGF Stock News Headlines

Brenntag SE (OTCMKTS:BNTGF) Short Interest Update
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Brenntag Confirms Preliminary Talks To Buy Univar Solutions
Breaking News: Passt! Massive Kurs-Konsequenzen erwartet!
Brenntag SE (BNTGF) Q3 2022 Earnings Call Transcript
Brenntag Q3 Profit Surges As Revenues Leap
Brenntag Q2 Profit Rises
Brenntag SE raises forecast for the financial year 2022
DGAP-Adhoc: Brenntag SE raises forecast for the financial year 2022
What Wall Street expects from Brenntag SE's earnings
Brenntag Q1 Profit Rises - Quick Facts
See More Headlines
Receive BNTGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brenntag and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:BNTGF
Fax
N/A
Employees
17,812
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Christian Kohlpaintner (Age 60)
    Chairman of the Management Board & CEO
    Comp: $2.39M
  • Dr. Kristin Neumann (Age 51)
    CFO & Member of the Management Board
    Comp: $1.23M
  • Mr. Steven H. J. Terwindt (Age 56)
    COO of Brenntag Essentials & Member of the Management Board
    Comp: $1.29M
  • Mr. Ewout Van Jarwaarde
    Chief Transformation Officer & Member of the Management Board
  • Mr. Michael Friede (Age 43)
    COO of Brenntag Specialties & Member of the Board of Management
  • Mr. Thomas Altmann
    Sr. VP of Investor Relations
  • Ms. Marion J. G. Mestrom (Age 62)
    Chief HR Officer
  • Ms. Ursula Baumgartner-Durchschlag
    Head of Laboratory & Qualified Person













BNTGF Stock - Frequently Asked Questions

How have BNTGF shares performed in 2023?

Brenntag's stock was trading at $63.5901 at the beginning of the year. Since then, BNTGF shares have increased by 24.2% and is now trading at $79.00.
View the best growth stocks for 2023 here
.

Are investors shorting Brenntag?

Brenntag saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 422,400 shares, an increase of 7.9% from the August 15th total of 391,500 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 4,224.0 days.
View Brenntag's Short Interest
.

Is Brenntag a good dividend stock?

Brenntag (OTCMKTS:BNTGF) pays an annual dividend of $0.87 per share and currently has a dividend yield of 2.16%. The dividend payout ratio is 37.34%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Brenntag's stock symbol?

Brenntag trades on the OTCMKTS under the ticker symbol "BNTGF."

How do I buy shares of Brenntag?

Shares of BNTGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Brenntag's stock price today?

One share of BNTGF stock can currently be purchased for approximately $79.00.

How many employees does Brenntag have?

The company employs 17,812 workers across the globe.

How can I contact Brenntag?

Brenntag's mailing address is Messeallee 11, Essen, Nordrhein-Westfalen 45131. The official website for the company is www.brenntag.com. The company can be reached via phone at (492) 016-4960.

This page (OTCMKTS:BNTGF) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -